Home / BDI biotech Production Plant /

BDI biotech Production Plant

We work as an R&D department specialized in strain and bioprocess development, scale-up and batches production.

Spain Europe

BDI biotech Production Plant

We work as an R&D department specialized in strain and bioprocess development, scale-up and batches production.

BDI biotech Production Plant

About the plant

BDI biotech is a Spanish company specialized in bringing ideas from bench to reality, working as an R&D department focused in strain and bioprocess development, scale-up and batches production. We work as an R&D department specialized in strain and bioprocess development, scale-up and batches production.

Our facility count with Process Development Labs and a non-GMP production line up to 500L:

Process Development Labs

The Process Development Facilities are equipped with a variety of industrial solutions, including glass, stainless steel, and single-use bioreactors from 1 to 30L. All the different upstream scales, counts with the associate downstream like HPH, centrifuges, depth filtrations, TFF and chromatography equipment. This process development service is tailored to each client’s specific needs and can be conducted either prior to cGMP production launch or as part of technology transfer from the client’s facilities to ours. Our customer-centric approach ensures efficient, robust, and scalable process development, supported by cutting-edge facilities and equipment.

Line 1 - Up to 500L non-GMP

Our non-GMP production boasts versatile capabilities with a reactor of 100L and another one of 500L. Both with dedicated centrifuge, high pressure homogenization unit, filtration skids and holders, chromatography equipments, and auxiliary tanks. Whether you´re embarking on early-stage research or scaling up BDI biotech facility is tailored to deliver excellence at every stage.


Certifications
  • ISO

Activity
  • Peptide, protein, hormone & enzyme, LBP (Live Biotherapeutic Products), BIOLOGICS manufacturing

Features
  • Uses: Investigational, Preclinical
  • Toxicity (OEB classification):
  • DEA: N/A
  • BSL: 1
  • Therapeutic areas: N/A
  • Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA (Colombia), MSPAS (Guatemala), ISP (Chile), FDA (USA), EMA (EU), Health Canada (Canada), MHRA (UK), TGA (Australia), ANVISA (Brazil), ANMAT (Argentina)

Batch Size / Reactor
  • Small, Medium, Batch, Fed-batch, 1 - 100 L, 100 - 1000 L

Services
  • Regulatory services, Development services, Manufacturing services, Analytical / QC services, Logistics, R&D, Process development, Process optimization, Downstream, Fill&Finish, Cell line development, Cell banking, Sterile product manufacturing, Non sterile product manufacturing, Upstream, Tech transfer, Pilot plant, Research batches, Scale-up, Pilot batches, Analytical methods development, Bioanalysis, Analytical methods transfer, Storage, CMC regulatory support

Get in touch
Address: 13 Louis Proust St. Boecillo
Spain
Year: 2017
Contact the CDMO commercial and technical team directly

I have read and accept the Terms and Conditions and the Privacy Policy.

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.

Want to see all the information?

Unleash the full power of MAI CDMO

Register for free

Ascil
CGAM
Lannett
Cambrex
Histocell
53Biologics